Author
Listed:
- Luciano Caero
- Juliana Libertelli
Abstract
The article discusses the concept of Vigorexia, also known as the Adonis Complex or Muscle Dysmorphia, which is a mental illness characterized by an obsession with body image, particularly muscularity. It was first named by psychiatrist Harrison G. Pope in the 1990s when studying weightlifters in a Boston gym. Vigorexia leads individuals to perceive themselves as small and weak despite having a muscular appearance. Some experts view Vigorexia as a behavioral addiction, marked by an obsession with exercise and the consumption of substances like anabolic steroids to increase muscle mass. It is often associated with distorted body image and dissatisfaction with one's appearance. The article highlights that Vigorexia has not always been recognized as a distinct disorder and was not initially included in diagnostic manuals. Anabolic steroids, testosterone, and growth hormones are commonly abused substances among individuals with Vigorexia, contributing to physical and mental health problems. Long-term use of these substances can lead to severe health issues, including psychosis. The article also touches on the impact of the COVID-19 pandemic on recreational bodybuilding practitioners, as lockdowns and social distancing measures disrupted their routines, potentially exacerbating anxiety and sadness. Additionally, it distinguishes between general physical activity and bodybuilding, with the latter emphasizing muscle development, strength, and aesthetics. The practice of bodybuilding often involves weightlifting and specialized machinery in gyms. In summary, Vigorexia is a mental disorder characterized by an obsession with muscularity, distorted body image, and the abuse of substances like anabolic steroids. It has physical and mental health consequences and has become more prevalent in recent years, affecting both athletes and non-athletes.
Suggested Citation
Handle:
RePEc:dbk:sicomu:2023v1a33
DOI: 10.62486/sic202319
Download full text from publisher
To our knowledge, this item is not available for
download. To find whether it is available, there are three
options:
1. Check below whether another version of this item is available online.
2. Check on the provider's
web page
whether it is in fact available.
3. Perform a
for a similarly titled item that would be
available.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:dbk:sicomu:2023v1a33. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Javier Gonzalez-Argote (email available below). General contact details of provider: https://sic.ageditor.org/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.